Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001437749-25-009095
Filing Date
2025-03-25
Accepted
2025-03-25 14:46:09
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM F-1/A gene20250325_f1a.htm F-1/A 2850216
2 EXHIBIT 1.1 ex_794110.htm EX-1.1 290175
3 EXHIBIT 4.1 ex_794111.htm EX-4.1 1764
4 EXHIBIT 5.1 ex_794181.htm EX-5.1 46669
5 EXHIBIT 5.2 ex_794112.htm EX-5.2 10496
6 EXHIBIT 21.1 ex_794109.htm EX-21.1 1168
7 c01.jpg GRAPHIC 553986
8 c02.jpg GRAPHIC 373855
9 frfooter.jpg GRAPHIC 21447
10 frlogo.jpg GRAPHIC 21038
11 gen_logo.jpg GRAPHIC 25258
12 gene20241220_correspimg003.jpg GRAPHIC 2469
13 gene20241220_correspimg004.jpg GRAPHIC 2469
14 gene20241220_correspimg005.jpg GRAPHIC 6801
15 gene20241220_correspimg006.jpg GRAPHIC 6801
16 graph01.jpg GRAPHIC 57791
17 image01.jpg GRAPHIC 11094
  Complete submission text file 0001437749-25-009095.txt   4694617
Mailing Address LEVEL 14, AUSTRALIA SQUARE 264-278 GEORGE STREET SYDNEY C3 NSW 2000
Business Address LEVEL 14, AUSTRALIA SQUARE 264-278 GEORGE STREET SYDNEY C3 NSW 2000 61411282401
GenEmbryomics Ltd (Filer) CIK: 0002038033 (see all company filings)

EIN.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-285074 | Film No.: 25767671
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)